Human neutrophil peptides: A novel potential mediator of inflammatory cardiovascular diseases

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 295, Issue 5, 2008, Pages

  Quinn, Kieran ^a,b,c   Henriques, Melanie ^a,b,c   Parker, Tom ^a,b   Slutsky, Arthur S ^a,c   Zhang, Haibo ^a,b,c,d  

^a ST MICHAEL'S HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d Queen Wing   (Canada)

Author keywords

Cytokine; Inflammation; defensins

Indexed keywords

ALPHA DEFENSIN; B7 ANTIGEN; CD86 ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1; LOW DENSITY LIPOPROTEIN;

ACUTE CORONARY SYNDROME; ANGIOGENESIS; ATHEROSCLEROSIS; BLOOD VESSEL WALL; CELL ACTIVATION; CELL ADHESION; CELL DIFFERENTIATION; CELL FUNCTION; CELL MIGRATION; CELL PROLIFERATION; CORONARY ARTERY DISEASE; CYTOTOXICITY; DISEASE COURSE; DISEASE SEVERITY; DISORDERS OF LIPID AND LIPOPROTEIN METABOLISM; ENDOTHELIAL DYSFUNCTION; FIBRINOLYSIS; FOAM CELL; HUMAN; INNATE IMMUNITY; LEUKOCYTE; MACROPHAGE; NEUTROPHIL; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN SECRETION; REVIEW; SEPSIS; T LYMPHOCYTE;

EID: 57049188278     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00472.2008     Document Type: Review

References (141)

1. Aarbiou J, Rabe KF, Hiemstra PS. Role of defensins in inflammatory lung disease. Ann Med 34: 96-101, 2002.
2. Adams DH, Shaw S. Leucocyte-endothelial interactions and regulation of leucocyte migration. Lancet 343: 831-836, 1994.
3. Adrie C, Laurent I, Monchi M, Cariou A, Dhainaou JF, Spaulding C. Postresuscitation disease after cardiac arrest: a sepsis-like syndrome? Curr Opin Crit Care 10: 208-212, 2004.
4. Ashitani J, Mukae H, Hiratsuka T, Nakazato M, Kumamoto K, Matsukura S. Elevated levels of alpha-defensins in plasma and BAL fluid of patients with active pulmonary tuberculosis. Chest 121: 519-526, 2002.
5. Assmann G, Carmena R, Cullen P, Fruchart JC, Jossa F, Lewis B, Mancini M, Paoletti R. Coronary heart disease: reducing the risk: a worldwide view. International Task Force for the Prevention of Coronary Heart Disease. Circulation 100: 1930-1938, 1999.
6. Avanzas P, Arroyo-Espliguero R, Cosin-Sales J, Aldama G, Pizzi C, Quiles J, Kaski JC. Markers of inflammation and multiple complex stenoses (pancoronary plaque vulnerability) in patients with non-ST segment elevation acute coronary syndromes. Heart 90: 847-852, 2004.
7. Avanzas P, Arroyo-Espliguero R, Cosin-Sales J, Quiles J, Zouridakis E, Kaski JC. Multiple complex stenoses, high neutrophil count and C-reactive protein levels in patients with chronic stable angina. Atherosclerosis 175: 151-157, 2004.
8. Barnathan ES, Raghunath PN, Tomaszewski JE, Ganz T, Cines DB, Higazi A al-R. Immunohistochemical localization of defensin in human coronary vessels. Am J Pathol 150: 1009-1020, 1997.
9. Bdeir K, Cane W, Canziani G, Chaiken I, Weisel J, Koschinsky ML, Lawn RM, Bannerman PG, Sachais BS, Kuo A, Hancock MA, Tomaszewski J, Raghunath PN, Ganz T, Higazi AA, Cines DB. Defensin promotes the binding of lipoprotein(a) to vascular matrix. Blood 94: 2007-2019, 1999.
10. Binder RJ, Han DK, Srivastava PK. CD91: a receptor for heat shock protein gp96. Nat Immunol 1: 151-155, 2000.
11. Bini A, Fenoglio JJ Jr, Mesa-Tejada R, Kudryk B, Kaplan KL. Identification and distribution of fibrinogen, fibrin, and fibrin(ogen) degradation products in atherosclerosis. Use of monoclonal antibodies. Arteriosclerosis 9: 109-121, 1989.
12. -/- mice reveals a role for chemokines in the initiation of atherosclerosis. Nature 394: 894-897, 1998.
13. Boullier A, Bird DA, Chang MK, Dennis EA, Friedman P, Gillotre-Taylor K, Horkko S, Palinski W, Quehenberger O, Shaw P, Steinberg D, Terpstra V, Witztum JL. Scavenger receptors, oxidized LDL, and atherosclerosis. Ann NY Acad Sci 947: 214-222, 2001.
14. Boussiotis VA, Freeman GJ, Gribben JG, Nadler LM. The role of B7-1/B7-2:CD28/CLTA-4 pathways in the prevention of anergy, induction of productive immunity and down-regulation of the immune response. Immunol Rev 153: 5-26, 1996.
15. Chaly YV, Paleolog EM, Kolesnikova TS, Tikhonov II, Petratchenko EV, Voitenok NN. Neutrophil alpha-defensin human neutrophil peptide modulates cytokine production in human monocytes and adhesion molecule expression in endothelial cells. Eur Cytokine Netw 11: 257-266, 2000.
16. Charo IF, Taubman MB. Chemokines in the pathogenesis of vascular disease. Circ Res 95: 858-866, 2004.
17. Chavakis T, Cines DB, Rhee JS, Liang OD, Schubert U, Hammes HP, Higazi AA, Nawroth PP, Preissner KT, Bdeir K. Regulation of neovascularization by human neutrophil peptides (alpha-defensins): a link between inflammation and angiogenesis. FASEB J 18: 1306-1308, 2004.
18. Chen P, Shibata M, Zidovetzki R, Fisher M, Zlokovic BV, Hofman FM. Endothelin-1 and monocyte chemoattractant protein-1 modulation in ischemia and human brain-derived endothelial cell cultures. J Neuroimmunol 116: 62-73, 2001.
19. Chertov O, Michiel DF, Xu L, Wang JM, Tani K, Murphy WJ, Longo DL, Taub DD, Oppenheim JJ. Identification of defensin-1, defensin-2, and CAP37/azurocidin as T-cell chemoattractant proteins released from interleukin-8-stimulated neutrophils. J Biol Chem 271: 2935-2940, 1996.
20. Coller BS. Leukocytosis and ischemic vascular disease morbidity and mortality: is it time to intervene? Arterioscler Thromb Vasc Biol 25: 658-670, 2005.
21. Cybulsky MI, Gimbrone MA Jr. Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis. Science 251: 788-791, 1991.
22. Daugherty A, Webb NR, Rateri DL, King VL. Thematic review series: the immune system and atherogenesis. Cytokine regulation of macrophage functions in atherogenesis. J Lipid Res 46: 1812-1822, 2005.
23. De Villiers WJ, Smart EJ. Macrophage scavenger receptors and foam cell formation. J Leukoc Biol 66: 740-746, 1999.
24. Di Virgilio F, Solini A. P2 receptors: new potential players in atherosclerosis. Br J Pharmacol 135: 831-842, 2002.
25. Dorweiler B, Torzewski M, Dahm M, Kirkpatrick CJ, Lackner K, Vahl C. Subendothelial infiltration of neutrophil granulocytes and liberation of matrix-destabilizing enzymes in an experimental model of human neo-intima. Thromb Haemost 99: 373-381, 2008.
26. Eisenhauer PB, Lehrer RI. Mouse neutrophils lack defensins. Infect Immun 60: 3446-3447, 1992.
27. Febbraio M, Hajjar DP, Silverstein RL. CD36: a class B scavenger receptor involved in angiogenesis, atherosclerosis, inflammation, and lipid metabolism. J Clin Invest 108: 785-791, 2001.
28. Febbraio M, Podrez EA, Smith JD, Hajjar DP, Hazen SL, Hoff HF, Sharma K, Silverstein RL. Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice. J Clin Invest 105: 1049-1056, 2000.
29. Freeman BA, Jackson RM, Matalon S, Harding SM. Endothelial Cells. Boca Raton, FL: CRC, 1988, p. 208.
30. Freeman MW. Scavenger receptors in atherosclerosis. Curr Opin Hematol 4: 41-47, 1997.
31. Gando S, Nanzaki S, Morimoto Y, Kobayashi S, Kemmotsu O. Alterations of soluble L- and P-selectins during cardiac arrest and CPR. Intensive Care Med 25: 588-593, 1999.
32. Gando S, Nanzaki S, Morimoto Y, Kobayashi S, Kemmotsu O. Out-of-hospital cardiac arrest increases soluble vascular endothelial adhesion molecules and neutrophil elastase associated with endothelial injury. Intensive Care Med 26: 38-44, 2000.
33. Ganz T. Defensins: antimicrobial peptides of innate immunity. Nat Rev Immunol 3: 710-720, 2003.
34. Ganz T. Extracellular release of antimicrobial defensins by human polymorphonuclear leukocytes. Infect Immun 55: 568-571, 1987.
35. Ganz T, Lehrer RI. Defensins. Curr Opin Immunol 6: 584-589, 1994.
36. Gerrity RG. The role of the monocyte in atherogenesis: I. Transition of blood-borne monocytes into foam cells in fatty lesions. Am J Pathol 103: 181-190, 1981.
37. Gilutz H, Siegel Y, Paran E, Cristal N, Quastel MR. Alpha 1-antitrypsin in acute myocardial infarction. Br Heart J 49: 26-29, 1983.
38. Glass CK, Witztum JL. Atherosclerosis the road ahead. Cell 104: 503-516, 2001.
39. Gowda RM, Fox JT, Khan IA. Cardiogenic shock: basics and clinical considerations. Int J Cardiol 123: 221-228, 2008.
40. Granger D. Physiology and Pathophysiology of Leukocyte Adhesion (1st ed.). Oxford: Oxford University Press, 1995.
41. Grigat J, Soruri A, Forssmann U, Riggert J, Zwirner J. Chemoattraction of macrophages, T lymphocytes, and mast cells is evolutionarily conserved within the human alpha-defensin family. J Immunol 179: 3958-3965, 2007.
42. Gu L, Okada Y, Clinton SK, Gerard C, Sukhova GK, Libby P, Rollins BJ. Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice. Mol Cell 2: 275-281, 1998.
43. Guasti L, Marino F, Cosentino M, Maio RC, Rasini E, Ferrari M, Castiglioni L, Klersy C, Gaudio G, Grandi AM, Lecchini S, Venco A. Prolonged statin-associated reduction in neutrophil reactive oxygen species and angiotensin II type 1 receptor expression: 1-year follow-up. Eur Heart J 29: 1118-1126, 2008.
44. Guzik TJ, Korbut R, Adamek-Guzik T. Nitric oxide and superoxide in inflammation and immune regulation. J Physiol Pharmacol 54: 469-487, 2003.
45. Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 352: 1685-1695, 2005.
46. Haumer M, Amighi J, Exner M, Mlekusch W, Sabeti S, Schlager O, Schwarzinger I, Wagner O, Minar E, Schillinger M. Association of neutrophils and future cardiovascular events in patients with peripheral artery disease. J Vasc Surg 41: 610-617, 2005.
47. Hechler B, Freund M, Ravanat C, Magnenat S, Cazenave JP, Gachet C. Reduced atherosclerotic lesions in P2Y1/apolipoprotein E double-knockout mice: the contribution of non-hematopoietic-derived P2Y1 receptors. Circulation 118: 754-763, 2008.
48. Henry J, Miller MM, Pontarotti P. Structure and evolution of the extended B7 family. Immunol Today 20: 285-288, 1999.
49. Higazi AA, Ganz T, Kariko K, Cines DB. Defensin modulates tissue-type plasminogen activator and plasminogen binding to fibrin and endothelial cells. J Biol Chem 271: 17650-17655, 1996.
50. Higazi AA, Lavi E, Bdeir K, Ulrich AM, Jamieson DG, Rader DJ, Usher DC, Kane W, Ganz T, Cines DB. Defensin stimulates the binding of lipoprotein (a) to human vascular endothelial and smooth muscle cells. Blood 89: 4290-4298, 1997.
51. Higazi AA, Nassar T, Ganz T, Rader DJ, Udassin R, Bdeir K, Hiss E, Sachais BS, Williams KJ, Leitersdorf E, Cines DB. The alpha-defensins stimulate proteoglycan-dependent catabolism of low-density lipoprotein by vascular cells: a new class of inflammatory apolipoprotein and a possible contributor to atherogenesis. Blood 96: 1393-1398, 2000.
52. Hirano K, Yamashita S, Nakagawa Y, Ohya T, Matsuura F, Tsukamoto K, Okamoto Y, Matsuyama A, Matsumoto K, Miyagawa J, Matsuzawa Y. Expression of human scavenger receptor class B type I in cultured human monocyte-derived macrophages and atherosclerotic lesions. Circ Res 85: 108-116, 1999.
53. Hofman FM, Chen P, Jeyaseelan R, Incardona F, Fisher M, Zidovetzki R. Endothelin-1 induces production of the neutrophil chemotactic factor interleukin-8 by human brain-derived endothelial cells. Blood 92: 3064-3072, 1998.
54. Huang JS. Alpha-2-macroglobulin - a modulator for growth factors? Am J Respir Cell Mol Biol 1: 169-170, 1989.
55. Huber R, Carrell RW. Implications of the three-dimensional structure of alpha 1-antitrypsin for structure and function of serpins. Biochemistry 28: 8951-8966, 1989.
56. Ihi T, Nakazato M, Mukae H, Matsukura S. Elevated concentrations of human neutrophil peptides in plasma, blood, and body fluids from patients with infections. Clin Infect Dis 25: 1134-1140, 1997.
57. Itabe H. Oxidized low-density lipoproteins: what is understood and what remains to be clarified. Biol Pharm Bull 26: 1-9, 2003.
58. Kanegasaki S, Nomura Y, Nitta N, Akiyama S, Tamatani T, Goshoh Y, Yoshida T, Sato T, Kikuchi Y. A novel optical assay system for the quantitative measurement of chemotaxis. J Immunol Methods 282: 1-11, 2003.
59. Kaski JC, Avanzas P, Arroyo-Espliguero R. Neutrophil count and complex lesions in patients with coronary artery disease. Arterioscler Thromb Vasc Biol 25: e112, 2005.
60. Khine AA, Del Sorbo L, Vaschetto R, Voglis S, Tullis E, Slutsky AS, Downey GP, Zhang H. Human neutrophil peptides induce interleukin-8 production through the P2Y6 signaling pathway. Blood 107: 2936-2942, 2006.
61. Klotman ME, Chang TL. Defensins in innate antiviral immunity. Nat Rev Immunol 6: 447-456, 2006.
62. Kokryakov VN, Harwig SS, Panyutich EA, Shevchenko AA, Aleshina GM, Shamova OV, Korneva HA, Lehrer RI. Protegrins: leukocyte antimicrobial peptides that combine features of corticostatic defensins and tachyplesins. FEBS Lett 327: 231-236, 1993.
63. Kougias P, Chai H, Lin PH, Yao Q, Lumsden AB, Chen C. Defensins and cathelicidins: neutrophil peptides with roles in inflammation, hyperlipidemia and atherosclerosis. J Cell Mol Med 9: 3-10, 2005.
64. Kougias P, Chai H, Lin PH, Yao Q, Lumsden AB, Chen C. Neutrophil antimicrobial peptide alpha-defensin causes endothelial dysfunction in porcine coronary arteries. J Vasc Surg 43: 357-363, 2006.
65. Krishnagopalan S, Kumar A, Parrillo JE, Kumar A. Myocardial dysfunction in the patient with sepsis. Curr Opin Crit Care 8: 376-388, 2002.
66. Kuchenhoff A, Harrach-Ruprecht B, Robenek H. Interaction of apo E-containing lipoproteins with the LDL receptor-related protein LRP. Am J Physiol Cell Physiol 272: C369-C382, 1997.
67. Leitinger N. Oxidized phospholipids as modulators of inflammation in atherosclerosis. Curr Opin Lipidol 14: 421-430, 2003.
68. Li AC, Glass CK. The macrophage foam cell as a target for therapeutic intervention. Nat Med 8: 1235-1242, 2002.
69. Li Y, Wood N, Parsons PG, Yellowlees D, Donnelly PK. Expression of alpha2-macroglobulin receptor/low density lipoprotein receptor-related protein on surfaces of tumour cells: a study using flow cytometry. Cancer Lett 111: 199-205, 1997.
70. Libby P. Inflammation in atherosclerosis. Nature 420: 868-874, 2002.
71. Libby P, Ross R. Cytokines and growth regulatory molecules. In: Atherosclerosis and Coronary Artery Disease, edited by Fuster V, Ross R, and Topol EJ. Philidelphia: Lippincott-Raven, 1996, p. 585-594.
72. Linton MF, Fazio S. Class A scavenger receptors, macrophages, and atherosclerosis. Curr Opin Lipidol 12: 489-495, 2001.
73. Llorente-Cortes V, Badimon L. LDL receptor-related protein and the vascular wall: implications for atherothrombosis. Arterioscler Thromb Vasc Biol 25: 497-504, 2005.
74. Lopez-Bermejo A, Chico-Julia B, Castro A, Recasens M, Esteve E, Biarnes J, Casamitjana R, Ricart W, Fernandez-Real JM. Alpha defensins 1, 2, and 3. Potential roles in dyslipidemia and vascular dysfunction in humans. Arterioscler Thromb Vasc Biol 27: 1166-1171, 2007.
75. Ludewig B, Freigang S, Jaggi M, Kurrer MO, Pei YC, Vlk L, Odermatt B, Zinkernagel RM, Hengartner H. Linking immune-mediated arterial inflammation and cholesterol-induced atherosclerosis in a transgenic mouse model. Proc Natl Acad Sci USA 97: 12752-12757, 2000.
76. Lusis AJ. Atherosclerosis. Nature 407: 233-241, 2000.
77. Mackay CR. Chemokine receptors and T cell chemotaxis. J Exp Med 184: 799-802, 1996.
78. Mackewicz CE, Yuan J, Tran P, Diaz L, Mack E, Selsted ME, Levy JA. Alpha-defensins can have anti-HIV activity but are not CD8 cell anti-HIV factors. AIDS 17: F23-F32, 2003.
79. Madjid M, Awan I, Willerson JT, Casscells SW. Leukocyte count and coronary heart disease: implications for risk assessment. J Am Coll Cardiol 44: 1945-1956, 2004.
80. Mazor R, Shurtzswirski R, Farah R, Kristal B, Shapiro G, Dorlechter F, Cohenmazor M, Meilin E, Tamara S, Sela S. Primed polymorphonuclear leukocytes constitute a possible link between inflammation and oxidative stress in hyperlipidemic patients. Atherosclerosis 197: 937-943, 2008.
81. McGettrick HM, Lord JM, Wang KQ, Rainger GE, Buckley CD, Nash GB. Chemokine- and adhesion-dependent survival of neutrophils after transmigration through cytokine-stimulated endothelium. J Leukoc Biol 79: 779-788, 2006.
82. McMurray HF, Parthasarathy S, Steinberg D. Oxidatively modified low density lipoprotein is a chemoattractant for human T lymphocytes. J Clin Invest 92: 1004-1008, 1993.
83. Mehta J, Dinerman J, Mehta P, Saldeen TG, Lawson D, Donnelly WH, Wallin R. Neutrophil function in ischemic heart disease. Circulation 79: 549-556, 1989.
84. Nakagawa-Toyama Y, Yamashita S, Miyagawa J, Nishida M, Nozaki S, Nagaretani H, Sakai N, Hiraoka H, Yamamori K, Yamane T, Hirano K, Matsuzawa Y. Localization of CD36 and scavenger receptor class A in human coronary arteries - a possible difference in the contribution of both receptors to plaque formation. Atherosclerosis 156: 297-305, 2001.
85. Nakata A, Nakagawa Y, Nishida M, Nozaki S, Miyagawa J, Nakagawa T, Tamura R, Matsumoto K, Kameda-Takemura K, Yamashita S, Matsuzawa Y. CD36, a novel receptor for oxidized low-density lipoproteins, is highly expressed on lipid-laden macrophages in human atherosclerotic aorta. Arterioscler Thromb Vasc Biol 19: 1333-1339, 1999.
86. Narita M, Holtzman DM, Schwartz AL, Bu G. Alpha2-macroglobulin complexes with and mediates the endocytosis of beta-amyloid peptide via cell surface low-density lipoprotein receptor-related protein. J Neurochem 69: 1904-1911, 1997.
87. Naruko T, Ueda M, Haze K, van der Wal AC, van der Loos CM, Itoh A, Komatsu R, Ikura Y, Ogami M, Shimada Y, Ehara S, Yoshiyama M, Takeuchi K, Yoshikawa J, Becker AE. Neutrophil infiltration of culprit lesions in acute coronary syndromes. Circulation 106: 2894-2900, 2002.
88. Nassar H, Lavi E, Akkawi S, Bdeir K, Heyman SN, Raghunath PN, Tomaszewski J, Higazi AA. Alpha-defensin: link between inflammation and atherosclerosis. Atherosclerosis 194: 452-457, 2007.
89. Nassar T, Akkawi S, Bar-Shavit R, Haj-Yehia A, Bdeir K, Al-Mehdi AB, Tarshis M, Higazi AA. Human alpha-defensin regulates smooth muscle cell contraction: a role for low-density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor. Blood 100: 4026-4032, 2002.
90. Nedeljkovic ZS, Gokce N, Loscalzo J. Mechanisms of oxidative stress and vascular dysfunction. Postgrad Med J 79: 195-199, 2003.
91. Okrent DG, Lichtenstein AK, Ganz T. Direct cytotoxicity of polymorphonuclear leukocyte granule proteins to human lung-derived cells and endothelial cells. Am Rev Respir Dis 141: 179-185, 1990.
92. Panyutich AV, Hiemstra PS, van Wetering S, Ganz T. Human neutrophil defensin and serpins form complexes and inactivate each other. Am J Respir Cell Mol Biol 12: 351-357, 1995.
93. Panyutich AV, Panyutich EA, Krapivin VA, Baturevich EA, Ganz T. Plasma defensin concentrations are elevated in patients with septicemia or bacterial meningitis. J Lab Clin Med 122: 202-207, 1993.
94. Porro GA, Lee JH, de Azavedo J, Crandall I, Whitehead T, Tullis E, Ganz T, Liu M, Slutsky AS, Zhang H. Direct and indirect bacterial killing functions of neutrophil defensins in lung explants. Am J Physiol Lung Cell Mol Physiol 281: L1240-L1247, 2001.
95. Quinn MT, Parthasarathy S, Fong LG, Steinberg D. Oxidatively modified low density lipoproteins: a potential role in recruitment and retention of monocyte/macrophages during atherogenesis. Proc Natl Acad Sci USA 84: 2995-2998, 1987.
96. Raines EW, Rosenfeld ME, Ross R. The role of macrophages. In: Atherosclerosis and Coronary Artery Disease, edited by Fuster V, Ross R, and Topol EJ. Philidelphia: Lippincott-Raven, 1996, p. 492-510.
97. Robbie LA, Booth NA, Brown AJ, Bennett B. Inhibitors of fibrinolysis are elevated in atherosclerotic plaque. Arterioscler Thromb Vasc Biol 16: 539-545, 1996.
98. Rodriguez-Garcia M, Oliva H, Climent N, Garcia F, Gatell JM, Gallart T. Human immature monocyte-derived dendritic cells produce and secrete alpha-defensins 1-3. J Leukoc Biol 82: 1143-1146, 2007.
99. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362: 801-809, 1993.
100. -/-/Lysozyme M(EGFP/EGFP) mice as a versatile model to study monocyte and neutrophil trafficking in atherosclerosis. Atherosclerosis. In press.
101. Sainz J, Sata M. Open sesame! CXCR4 blockade recruits neutrophils into the plaque. Circ Res 102: 154-156, 2008.
102. Sakamoto N, Mukae H, Fujii T, Ishii H, Yoshioka S, Kakugawa T, Sugiyama K, Mizuta Y, Kadota J, Nakazato M, Kohno S. Differential effects of α- and β-defensin on cytokine production by cultured human bronchial epithelial cells. Am J Physiol Lung Cell Mol Physiol 288: L508-L513, 2005.
103. Salame MY, Samani NJ, Masood I, deBono DP. Expression of the plasminogen activator system in the human vascular wall. Atherosclerosis 152: 19-28, 2000.
104. Savchenko A, Imamura M, Ohashi R, Jiang S, Kawasaki T, Hasegawa G, Emura I, Iwanari H, Sagara M, Tanaka T, Hamakubo T, Kodama T, Naito M. Expression of pentraxin 3 (PTX3) in human atherosclerotic lesions. J Pathol 215: 48-55, 2008.
105. Schulz S, Birkenmeier G, Schagdarsurengin U, Wenzel K, Muller-Werdan U, Rehfeld D, Suss T, Kabisch A, Werdan K, Glaser C. Role of LDL receptor-related protein (LRP) in coronary atherosclerosis. Int J Cardiol 92: 137-144, 2003.
106. Schulz S, Schagdarsurengin U, Greiser P, Birkenmeier G, Muller-Werdan U, Hagemann M, Riemann D, Werdan K, Glaser C. The LDL receptor-related protein (LRP1/A2MR) and coronary atherosclerosis - novel genomic variants and functional consequences. Hum Mutat 20: 404, 2002.
107. Schwartz CJ, Valente AJ, Kelley JL, Sprague EA, Edwards EH. Thrombosis and the development of atherosclerosis: Rokitansky revisited. Semin Thromb Hemost 14: 189-195, 1988.
108. Selsted ME, Harwig SS, Ganz T, Schilling JW, Lehrer RI. Primary structures of three human neutrophil defensins. J Clin Invest 76: 1436-1439, 1985.
109. 2 receptors in atherosclerosis and postangioplasty restenosis. Purinergic Signal 2: 471-480, 2006.
110. Sheikine Y, Hansson GK. Chemokines and atherosclerosis. Ann Med 36: 98-118, 2004.
111. Skalen K, Gustafsson M, Rydberg EK, Hulten LM, Wiklund O, Innerarity TL, Boren J. Subendothelial retention of atherogenic lipoproteins in early atherosclerosis. Nature 417: 750-754, 2002.
112. Springer TA. Adhesion receptors of the immune system. Nature 346: 425-434, 1990.
113. Spronk HM, van der Voort D, Ten Cate H. Blood coagulation and the risk of atherothrombosis: a complex relationship. Thromb J 2: 12, 2004.
114. Stakisaitis D, Basys V, Benetis R. Does alpha-1-proteinase inhibitor play a protective role in coronary atherosclerosis? Med Sci Monit 7: 701-711, 2001.
115. Steffens S, Mach F. Inflammation and atherosclerosis. Herz 29: 741-748, 2004.
116. Stemme S, Faber B, Holm J, Wiklund O, Witztum JL, Hansson GK. T lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein. Proc Natl Acad Sci USA 92: 3893-3897, 1995.
117. Stocker R, Keaney JF Jr. Role of oxidative modifications in atherosclerosis. Physiol Rev 84: 1381-1478, 2004.
118. Strickland DK, Gonias SL, Argraves WS. Diverse roles for the LDL receptor family. Trends Endocrinol Metab 13: 66-74, 2002.
119. Suzuki H, Kurihara Y, Takeya M, Kamada N, Kataoka M, Jishage K, Ueda O, Sakaguchi H, Higashi T, Suzuki T, Takashima Y, Kawabe Y, Cynshi O, Wada Y, Honda M, Kurihara H, Aburatani H, Doi T, Matsumoto A, Azuma S, Noda T, Toyoda Y, Itakura H, Yazaki Y, Horiuchi S, Takahashi K, Kruijt JK, Van Berkel TJC, Steinbrecher UP, Ishibashi S, Maeda N, Gordon S, Kodama T. A role for macrophage scavenger receptors in atherosclerosis and susceptibility to infection. Nature 386: 292-296, 1997.
120. Syeda F, Liu HY, Tullis E, Liu M, Slutsky AS, Zhang H. Differential signaling mechanisms of HNP-induced IL-8 production in human lung epithelial cells and monocytes. J Cell Physiol 214: 820 - 827, 2007.
121. Syeda F, Tullis E, Slutsky AS, Zhang H. Human neutrophil peptides upregulate expression of COX-2 and endothelin-1 by inducing oxidative stress. Am J Physiol Heart Circ Physiol 294: H2769-H2774, 2008.
122. Takahashi K, Takeya M, Sakashita N. Multifunctional roles of macrophages in the development and progression of atherosclerosis in humans and experimental animals. Med Electron Microsc 35: 179-203, 2002.
123. Tamminen M, Mottino G, Qiao JH, Breslow JL, Frank JS. Ultrastructure of early lipid accumulation in ApoE-deficient mice. Arterioscler Thromb Vasc Biol 19: 847-853, 1999.
124. Tani K, Murphy WJ, Chertov O, Salcedo R, Koh CY, Utsunomiya I, Funakoshi S, Asai O, Herrmann SH, Wang JM, Kwak LW, Oppenheim JJ. Defensins act as potent adjuvants that promote cellular and humoral immune responses in mice to a lymphoma idiotype and carrier antigens. Int Immunol 12: 691-700, 2000.
125. Tani S, Nagao K, Anazawa T, Kawamata H, Iida K, Matsumoto M, Sato Y, Hirayama A. Association of circulating leukocyte count with coronary atherosclerosis regression after pravastatin treatment. Atherosclerosis 198: 360-365, 2008.
126. Terkeltaub R, Boisvert WA, Curtiss LK. Chemokines and atherosclerosis. Curr Opin Lipidol 9: 397-405, 1998.
127. Territo MC, Ganz T, Selsted ME, Lehrer R. Monocyte-chemotactic activity of defensins from human neutrophils. J Clin Invest 84: 2017-2020, 1989.
128. Tupin E, Nicoletti A, Elhage R, Rudling M, Ljunggren HG, Hansson GK, Berne GP. CD1d-dependent activation of NKT cells aggravates atherosclerosis. J Exp Med 199: 417-422, 2004.
129. -/- mice. Arterioscler Thromb Vasc Biol 28: 84-89, 2008.
130. Van Wetering S, Mannesse-Lazeroms SP, Dijkman JH, Hiemstra PS. Effect of neutrophil serine proteinases and defensins on lung epithelial cells: modulation of cytotoxicity and IL-8 production. J Leukoc Biol 62: 217-226, 1997.
131. Van Wetering S, Mannesse-Lazeroms SP, Van Sterkenburg MA, Daha MR, Dijkman JH, Hiemstra PS. Effect of defensins on interleukin-8 synthesis in airway epithelial cells. Am J Physiol Lung Cell Mol Physiol 272: L888-L896, 1997.
132. Van Wetering S, Mannesse-Lazeroms SP, van Sterkenburg MA, Hiemstra PS. Neutrophil defensins stimulate the release of cytokines by airway epithelial cells: modulation by dexamethasone. Inflamm Res 51: 8-15, 2002.
133. + lymphocytes. J Leukoc Biol 81: 1022-1031, 2007.
134. Weber KS, Draude G, Erl W, de Martin R, Weber C. Monocyte arrest and transmigration on inflamed endothelium in shear flow is inhibited by adenovirus-mediated gene transfer of IkappaB-alpha. Blood 93: 3685-3693, 1999.
135. Wilhelmsen L, Svardsudd K, Korsan-Bengtsen K, Larsson B, Welin L, Tibblin G. Fibrinogen as a risk factor for stroke and myocardial infarction. N Engl J Med 311: 501-505, 1984.
136. Williams KJ, Tabas I. Lipoprotein retention - and clues for atheroma regression. Arterioscler Thromb Vasc Biol 25: 1536-1540, 2005.
137. Yang D, Chen Q, Chertov O, Oppenheim JJ. Human neutrophil defensins selectively chemoattract naive T and immature dendritic cells. J Leukoc Biol 68: 9-14, 2000.
138. Zarbock A, Polanowska-Grabowska RK, Ley K. Platelet-neutrophil- interactions: linking hemostasis and inflammation. Blood Rev 21: 99-111, 2007.
139. Zernecke A, Bot I, Djalali-Talab Y, Shagdarsuren E, Bidzhekov K, Meiler S, Krohn R, Schober A, Sperandio M, Soehnlein O, Bornemann J, Tacke F, Biessen EA, Weber C. Protective role of CXC receptor 4/CXC ligand 12 unveils the importance of neutrophils in atherosclerosis. Circ Res 102: 209-217, 2008.
140. Zernecke A, Weber C. Inflammatory mediators in atherosclerotic vascular disease. Basic Res Cardiol 100: 93-101, 2005.
141. Zhang H, Porro G, Orzech N, Mullen B, Liu M, Slutsky AS. Neutrophil defensins mediate acute inflammatory response and lung dysfunction in dose-related fashion. Am J Physiol Lung Cell Mol Physiol 280: L947-L954, 2001.